Impact of cytokine genotype on cardiovascular surrogate markers in hemodialysis patients

REFERENCES

• Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648–658.
   PubMed Web of Science ®Google Scholar
• Nishizawa Y, Shoji T, Maekawa K, Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2003;41(3 Suppl. 1):76–79.
   PubMed Web of Science ®Google Scholar
• Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36(2):286–290.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Benedetto FA, Mallamaci F, Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens. 2000;18(9):1207–1213.
   PubMedGoogle Scholar
• Wang AY, Wang M, Woo J, Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients. J Am Soc Nephrol. 2004;15(8):2186–2194.
   PubMed Web of Science ®Google Scholar
• Makhatadze NJ. Tumor necrosis factor locus: Genetic organization and biological implications. Hum Immunol. 1998;59(9):571–579.
   PubMed Web of Science ®Google Scholar
• Cope AP. Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol. 1998;10(6):669–676.
   PubMed Web of Science ®Google Scholar
• Van der Poll T, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJ. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med. 1994;180(5):1985–1988.
   PubMed Web of Science ®Google Scholar
• Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94(7):3195–3199.
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1–8.
   PubMedGoogle Scholar
• Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001;159(1):137–144.
   PubMed Web of Science ®Google Scholar
• Wang XL, Oosterhof J. Tumor necrosis factor alpha G-308 – A polymorphism and risk for coronary artery disease. Clin Sci (Lond). 2000;98(4):435–437.
   PubMed Web of Science ®Google Scholar
• Bernard V, Pillois X, Dubus I, The –308 G/A tumor necrosis factor-alpha gene dimorphism: A risk factor for unstable angina. Clin Chem Lab Med. 2003;41(4):511–516.
   PubMed Web of Science ®Google Scholar
• Girndt M, Kaul H, Sester U, Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 2002;62(3):949–955.
   PubMed Web of Science ®Google Scholar
• Lang RM, MD, Bierig M, Devereux RB, Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–1463.
   PubMed Web of Science ®Google Scholar
• Kawagishi T, Nishizawa Y, Konishi T, High resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820–826.
   PubMed Web of Science ®Google Scholar
• Pascazio L, Bianco F, Giorgini A, Echo color Doppler imaging of carotid vessels in hemodialysis patients: Evidence of high levels of atherosclerotic lesions. Am J Kidney Dis. 2002;28:713–720.
   Web of Science ®Google Scholar
• Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;13:499–502.
   Google Scholar
• Yao Q, Lindholm B, Stenvinkel P. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int. 2004;8:118–129.
   PubMedGoogle Scholar
• Baldassarre D, De Jong A, Amato M, Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med. 2008;40(1):21–44.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Horio T, Kamide K, C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertens Res. 2007;30(12):1177–1185.
   PubMed Web of Science ®Google Scholar
• Mehta SK, Rame JE, Khera A, Left ventricular hypertrophy, subclinical atherosclerosis, and inflammation hypertension. Hypertension. 2007;49(6):1385–1391.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Pecoits-Filho R, Lindholm B, for the DialGene Consortium. Gene polymorphism association studies in dialysis: The nutrition-inflammation axis. Semin Dial. 2005;18(4):322–330.
   PubMed Web of Science ®Google Scholar
• Jeanmonod P, von Känel R, Maly FE, Fischer JE. Elevated plasma C-reactive protein in chronically distressed subjects who carry the A allele of the TNF-alpha –308 G/A polymorphism. Psychosom Med. 2004;66(4):501–506.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Ketteler M, Johnson RJ, IL-10, IL-6, and TNF-alpha: Central factors in the altered cytokine network of uremia – the good, the bad, and the ugly. Kidney Int. 2005;67(4):1216–1233.
   PubMed Web of Science ®Google Scholar
• Abraham LJ, Kroeger KM. Impact of the –308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: Relevance to disease. J Leukoc Biol. 1999;66(4):562–566.
   PubMed Web of Science ®Google Scholar
• Vatay A, Bene L, Kovács A, Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics. 2003;55(4):247–252.
   PubMed Web of Science ®Google Scholar
• Pereira TV, Rudnicki M, Franco RF, Pereira AC, Krieger JE. Effect of the G-308A polymorphism of the tumor necrosis factor alpha gene on the risk of ischemic heart disease and ischemic stroke: A meta-analysis. Am Heart J. 2007;153(5):821–830.
   PubMed Web of Science ®Google Scholar
• Elahi M, Gilmour A, Matata BM, Mastana SS. A variant of position -308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease. Heart Lung Circ. 2008;17(1):14–18.
   PubMed Web of Science ®Google Scholar
• Balakrishnan VS, Guo D, Rao M, Cytokine gene polymorphisms in hemodialysis patients: Association with comorbidity, functionality, and serum albumin. Kidney Int. 2004;65:1449–1460.
   PubMed Web of Science ®Google Scholar
• Jaber BL, Rao M, Guo D, Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine. 2004;25(5):212–219.
   PubMed Web of Science ®Google Scholar
• Ram S, Bass K, Abreo K, Baier RJ, Kruger TE. Tumor necrosis factor-alpha −308 gene polymorphism is associated with synthetic hemodialysis graft failure. J Investig Med. 2003;51(1):19–26.
   PubMed Web of Science ®Google Scholar
• Buraczynska M, Mierzicki P, Buraczynska K, Dragan M, Ksiazek A. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol Diagn Ther. 2007;11(4):257–263.
   PubMed Web of Science ®Google Scholar
• Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35(3):469–476.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif. 2003;21(1):29–36.
   PubMed Web of Science ®Google Scholar
• Perunicic-Pekovic G, Pljesa S, Rasic-Milutinovic Z, Stankovic S, Ilic M, Maletic R. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients. Can J Physiol Pharmacol. 2008;86(4):205–209.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Hashimoto T, Kobayashi H, Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients. J Nephrol. 2003;16(5):641–649.
   PubMed Web of Science ®Google Scholar
• Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001;104(7):746–749.
   PubMed Web of Science ®Google Scholar